[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aura Biosciences Inc (AURA)

Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 800,215
  • Shares Outstanding, K 103,387
  • Annual Sales, $ 0 K
  • Annual Income, $ -106,190 K
  • EBIT $ -119 M
  • EBITDA $ -118 M
  • 60-Month Beta 0.40
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.03

Options Overview Details

View History
  • Implied Volatility 247.51% (-5.11%)
  • Historical Volatility 59.92%
  • IV Percentile 13%
  • IV Rank 13.67%
  • IV High 1,343.19% on 01/12/26
  • IV Low 73.97% on 01/13/26
  • Expected Move (DTE 14) 0.53 (6.81%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 233
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 3.95
  • Today's Open Interest 1,905
  • Open Int (30-Day) 2,863
  • Expected Range 7.21 to 8.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 2
  • High Estimate $-0.31
  • Low Estimate $-0.50
  • Prior Year $-0.47
  • Growth Rate Est. (year over year) +12.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.03 +28.36%
on 06/11/26
7.75 -0.13%
on 07/02/26
+0.84 (+12.17%)
since 06/02/26
3-Month
6.03 +28.36%
on 06/11/26
9.53 -18.83%
on 05/05/26
+1.20 (+18.35%)
since 04/02/26
52-Week
4.73 +63.64%
on 01/20/26
9.53 -18.83%
on 05/05/26
+1.28 (+19.81%)
since 07/02/25

Most Recent Stories

More News
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances

Aura Biosciences (NASDAQ:AURA) is shifting its focus toward regulatory preparation and commercialization planning as enrollment in its registrational CoMpass study of bel-sar in early choroidal melanoma...

AURA : 7.74 (+15.01%)
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the...

AURA : 7.74 (+15.01%)
Aura Biosciences Has Been Quietly Telling a New Story. Earnings Day Is When the Market Decides If It Believes It.

Barchart Research What to Expect from AURA Earnings AURA Generated March 27, 2026 Current Price $6.27 EPS Estimate $-0.43 Consensus Rating Strong Buy Average Move 3.65% Aura Biosciences Has Been Quietly...

AURA : 7.74 (+15.01%)
Aura Biosciences Has Been Quietly Telling a New Story. Earnings Day Is When the Market Decides If It Believes It.

Barchart Research What to Expect from AURA Earnings AURA Generated March 27, 2026 Current Price $6.27 EPS Estimate $-0.43 Consensus Rating Strong Buy Average Move 3.65% Aura Biosciences Has Been Quietly...

AURA : 7.74 (+15.01%)
Aura Biosciences Has Been Quietly Telling a New Story. Earnings Day Is When the Market Decides If It Believes It.

Barchart Research What to Expect from AURA Earnings AURA Generated March 27, 2026 Current Price $6.27 EPS Estimate $-0.43 Consensus Rating Strong Buy Average Move 3.65% Aura Biosciences Has Been Quietly...

AURA : 7.74 (+15.01%)

Business Summary

Aura Biosciences Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system. The company's lead product candidate includes AU-011. Aura Biosciences Inc. is based...

See More

Key Turning Points

3rd Resistance Point 9.30
2nd Resistance Point 8.53
1st Resistance Point 8.13
Last Price 7.74
1st Support Level 6.96
2nd Support Level 6.19
3rd Support Level 5.79

See More

52-Week High 9.53
Last Price 7.74
Fibonacci 61.8% 7.70
Fibonacci 50% 7.13
Fibonacci 38.2% 6.57
52-Week Low 4.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.